SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
Drug resistance
Journals
25
1
Frontiers in medicine
2
Molecular diversity
3
Journal of clinical nursing
4
Journal of global antimicrobial resistance
5
molecular pharmaceutics
6
Frontiers in bioengineering and biotechnology
7
mycopathologia
8
Viruses
9
case reports in infectious diseases
10
letters in applied microbiology
11
BMC genomics
12
the international journal of tuberculosis and lung disease : the official journal of the international union against tuberculosis and lung disease
13
Journal of translational medicine
14
genome medicine
15
global health, science and practice
16
antiviral chemistry & chemotherapy
17
reviews on environmental health
18
bmj open gastroenterology
19
expert review of medical devices
20
international journal for parasitology drugs and drug resistance
21
research (washington, dc)
22
parasite immunology
23
journal of chemotherapy (florence, italy)
24
Protein science : a publication of the Protein Society
25
international journal of clinical and experimental pathology
Research Groups
0
No Research Group Connected
Bibliographies
225
1
Population genomic and evolutionary modelling analyses reveal a single major QTL for ivermectin drug resistance in the pathogenic nematode, Haemonchus contortus.
2
Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
3
Carbon nanomaterials: a new way against tuberculosis.
4
Chemically Binding Scaffolded Anodes with 3D Graphene Architectures Realizing Fast and Stable Lithium Storage.
5
Structural Insights into Phosphopantetheinyl Hydrolase PptH from Mycobacterium tuberculosis.
6
Early Diagnosis of Latent Tuberculosis Reactivation due to Drug Interaction between Cobicistat and Intranasal Fluticasone.
7
Environmental pharmacology: source, impact and solution.
8
Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.
9
Social Media and Drug Resistance in Nursing Training: Using a Twitterchat to develop an international community of practice for antimicrobial resistance.
10
New approach to identify Colistin-resistant Pseudomonas aeruginosa by High-Resolution Melting Curve (HRM) Analysis assay.
11
The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey.
12
Autophagy-related genes affect drug resistance of mycobacteria by regulating autophagy.
13
Evaluation of MTBDR for detecting resistance in to second-line drugs.
14
Discovery and evaluation of inhibitory activity and mechanism of arylcoumarin derivatives on Theileria annulata enolase by in vitro and molecular docking studies.
15
Potential strategies for the management of drug resistant tuberculosis.
16
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
17
HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia.
18
A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis.
19
Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Associated With Pyrazinamide Resistance.
20
Effects of a Peer-Led Intervention on HIV Care Continuum Outcomes Among Contacts of Children, Adolescents, and Young Adults Living With HIV in Zimbabwe.
21
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study
22
phenotypic and transcriptional profiling in entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistance
23
bacterial profile and antimicrobial susceptibility pattern in catheter related nosocomial infections.
24
resistance of schistosomes to hycanthone and oxamniquine
25
prediction of cancer drug resistance and implications for personalized medicine.
26
incidence and antibiotic susceptibility pattern of most common bacterial pathogen causing urinary tract infection (uti) in tehran, iran, 2012-2013
27
patient automedication and professional prescription pattern in an urgency service in brazil
28
doença pulmonar por mycobacterium tuberculosis e micobactérias não-tuberculosas entre pacientes recém-diagnosticados como hiv positivos em moçambique, África mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent hiv infection in mozambique
29
breast cancer-initiating cells: insights into novel treatment strategies
30
chimerization at the aqp2–aqp3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical trypanosoma brucei gambiense isolates
31
drug susceptibility of plasmodium falciparum in the western amazon region, state of acre, brazil susceptibilidade a droga, do plasmodium falciparum, na amazônia ocidental, estado do acre, brasil
32
antimicrobial susceptibility pattern of pseudomonas aeruginosa isolated from patients referring to hospitals
33
the mechanism of ligand-independent activation of estrogen receptor in letrozole-resistant breast cancer cells
34
the presence of aac (6 ') ie / aph (2 "), aph (3') - iiia1, ant (4 ') - ia1 genes and determining methicillin resistance in staphylococcus epidermidis and staphylococcus saprophyticus strains isolated from clinical specimens
35
advanced cell culture techniques for cancer drug discovery
36
mutations in plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the amazon region of brazil
37
current status of poly(adp-ribose) polymerase inhibitors and future directions
38
oxidative phosphorylation activation is an important characteristic of dox resistance in hepatocellular carcinoma cells
39
política de antibióticos
40
a preliminary study on the screening of emerging drug resistance among the caries pathogens isolated from carious dentine
41
importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance
42
exploring small extracellular vesicles for precision medicine in prostate cancer
43
avances recientes en métodos moleculares para el diagnóstico precoz y tuberculosis resistente al tratamiento
44
proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer
45
caracterización de aislamientos invasivos de s. pneumoniae, h. influenzae y n. meningitidis en américa latina y el caribe: sireva ii, 2000-2005 characterization of invasive isolates of s. pneumoniae, h. influenzae, and n. meningitidis in latin america and the caribbean: sireva ii, 2000-2005
46
drug resistance analysis by next generation sequencing in leishmania
47
distribución de genes codificadores de β-lactamasas de espectro extendido en aislamientos de klebsiella pneumoniae de hospitales de bogotá, d.c., colombia
48
nanoparticles for control of biofilms of acinetobacter species
49
in-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant plasmodium falciparum.
50
genetic variation and drug resistance mutation of influenza virus during 2013-2014 in beijing, china: a report of 37 cases
51
the hsp90 co-chaperones sti1, aha1, and p23 regulate adaptive responses to antifungal azoles
52
inter and intratumour heterogeneity: a barrier to individualised medical therapy in renal cell carcinoma?
53
schistosome abc multidrug transporters: from pharmacology to physiology
54
prevalence of r-type acssut in strains of salmonella serovar typhimurium dt193 isolated from human infections in brazil prevalencia de resistencia de tipo acssut en cepas de salmonella serovariedad typhimurium dt193 aisladas a partir de infecciones humanas en el brasil
55
the molecular chaperone grp78/bip in the development of chemoresistance: mechanism and possible treatment
56
stat3-mediated metabolic reprogramming in cellular transformation and implications for drug resistance
57
vigilancia del consumo de antimicrobianos en hospitales de méxico: situación actual y guía práctica para su implementación surveillance of antimicrobial drug use in mexican hospitals: current situation and practical guidelines for its implementation
58
cell volume regulation in epithelial physiology and cancer
59
structural aspects of drug resistance and inhibition of hiv-1 reverse transcriptase
60
synergistic effect of haloduracin and chloramphenicol against clinically important gram-positive bacteria
61
susceptibilidad antimicrobiana y bases genéticas de la resistencia de cepas de enterococcus causantes de infecciones en cuba antimicrobial susceptibility and genetic bases for resistance of infection-causing enterococcus strains in cuba
62
role of integrin alpha4 in drug resistance of leukemia
63
clinical features of mycoplasma pneumoniae infections in the 2010 epidemic season: report of two cases with unusual presentations
64
efficacy of 3 anthelmintics in communally grazed sheep as reflected by faecal egg count reduction tests in a semi-arid area of south africa : short communication
65
unique flap conformation in an hiv-1 protease with high-level darunavir resistance
66
occurrence and antimicrobial resistance of salmonella spp. and escherichia coli isolates in apparently healthy slaughtered cattle, sheep and goats in east azarbaijan province
67
bacteriological study of neonatal septicaemia cases and their in vitro sensitivity to antimicrobial agents.
68
targeting intracellular calcium signaling ([ca2+]i) to overcome acquired multidrug resistance of cancer cells: a mini-overview
69
Abstracts from the 2012 BNOS Conference
70
The opposing roles of Wnt-5a in cancer - British Journal of Cancer
71
Nonantibiotic Treatment of Clinical Multidrug-Resistant Bacterial Isolates Using Chitosan Nanoparticles as a Carrier for the Supernatant of Mesenchymal Stem Cells.
72
Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
73
Pyocyanin, a Metabolite of Pseudomonas Aeruginosa, Exhibits Antifungal Drug Activity Through Inhibition of a Pleiotropic Drug Resistance Subfamily FgABC3.
74
Emerging roles of exosomal miRNAs in breast cancer drug resistance.
75
Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China
76
Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria
77
Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam
78
Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt
79
Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China
80
A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections
81
Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China
82
Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014
83
HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan
84
Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
85
Molecular analysis of multidrug resistance in clinical isolates of Shigella spp. from 2001–2010 in Kolkata, India: role of integrons, plasmids, and topoisomerase mutations
86
Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis [Corrigendum]
87
Potential and use of bacterial small RNAs to combat drug resistance: a systematic review
88
Different phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from Egypt
89
High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014
90
Current perspective on emergence, diagnosis and drug resistance in Candida auris
91
Drug resistance in influenza A virus: the epidemiology and management
92
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
93
Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
94
Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China
95
Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria
96
Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China
97
Epidemiology of Plasmodium falciparum infection and drug resistance markers in Ota Area, Southwestern Nigeria
98
Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India
99
Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam
100
Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt
101
Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China